LRRK2 and Autophagy.
Leucine-rich repeat kinase 2 (LRRK2) has been implicated in a wide range of cellular processes, including the catabolic pathways collectively described as autophagy. In this chapter, the evidence linking LRRK2 to autophagy will be examined, along with how regulation of autophagy and lysosomal pathways may provide a nexus between the physiological function of this protein and the different diseases with which it has been associated. Data from cellular and animal models for LRRK2 function and dysfunction support a role in the regulation and control of autophagic pathways in the cell, although the extant results do not provide a clear indication as to whether LRRK2 is a positive or negative regulator of these pathways, and there are conflicting data as to the impact of mutations in LRRK2 causative for Parkinson's disease. Given that LRRK2 is a priority drug target for Parkinson's, the evidence suggesting that knockout or inhibition of LRRK2 can result in deregulation of autophagy may have important implications and is discussed in the context of our wider understanding of LRRK2.
['Manzoni|Claudia|C|', 'Lewis|Patrick A|PA|']
D000818:Animals D001343:Autophagy D006801:Humans D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 D009154:Mutation D010300:Parkinson Disease
LRRK2 Catabolism Lysosomes Autophagosomes Macroautophagy Parkinson’s disease